Recent insider trading activity from Grossi Federico, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 6, 2025 | Unity Biotechnology, Inc. | $UNBX | Grossi Federico | Chief Medical Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 5, 2023 | Apellis Pharmaceuticals, Inc. | $APLS | Grossi Federico | Chief Medical Officer | S | Common Stock | 2500 | $48.79 | 94,884.0000 | 106,114,000 | 2.57% | 0.00% |